UROwebinar: Innovations in localised renal cell carcinoma (RCC): From biomarkers and molecular imaging to stereotactic body radiation therapy (SBRT)
Organised by the European School of Urology, the EAU Young Urology Office, and the Young Academic Urologists, this UROwebinar will explore the key innovations in the management of localised renal cell carcinoma (RCC).
| Organiser | European School of Urology |
|---|---|
| CME | 1.00 |
| Location | Online |
Through expert insights on stereotactic body radiotherapy (SBRT), biomarkers, and molecular imaging, we aim to clarify how these emerging tools can refine patient selection, improve treatment response assessment, and enhance disease characterisation.
The UROwebinar will address ongoing challenges in integrating novel technologies into clinical pathways and assess whether these approaches are ready for broader implementation.
By bringing multidisciplinary expertise together, this UROwebinar seeks to offer practical answers and perspectives on how to personalise care and push the boundaries of the current RCC management.
Faculty
Assoc. Prof. D. Amparore (IT)
Moderator
Dr. R. Campi (IT)
Moderator
Dr. Z. Tippu (GB)
Speaker
Dr. M.C. Mir Maresma (ES)
Speaker
Prof. Dr. P. Ost (BE)
Speaker